EPISODE · Jan 31, 2025 · 9 MIN
2031: Q&A with Oncimmune CEO, Martin Gouldstone
from The Vox Markets Podcast · host Vox Markets Podcast
Watch on YouTubeAfter this morning's trading update, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services to the Biopharma industry – takes me through the company's current demand picture, pipeline and August FY25 guidance.
NOW PLAYING
2031: Q&A with Oncimmune CEO, Martin Gouldstone
0:00
9:29
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 9 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on January 31, 2025.
What is this episode about?
Watch on YouTubeAfter this morning's trading update, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services to the Biopharma industry – takes me through the company's current demand picture,...
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!